C21 Investments Inc.

CWLXF ·Healthcare, Drug Manufacturers - General
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018
Operating Activities
Net Income $-599.5K
Depreciation & Amortization —
Depreciation —
Amortization —
Stock-Based Compensation $258.9K
Net Cash from Operating Activities $-583.3K
Investing Activities
Capital Expenditures —
Business Acquisitions —
Net Cash from Investing Activities $-299
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $693.3K
Net Change in Cash $209.2K
Free Cash Flow —
← Newer Page 2 of 2 Older →